RAPP
Rapport Therapeutics, Inc. · Healthcare · Market cap $1.2B
Insiders sold $5.4M net in the last 90 days ·3 sellers, 6 buyers· 13 of 13 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 23, 2026
Insider Buying
$1.7M
reported purchases (SEC code P)
Insider Selling
$47.2M
reported sales (SEC code S)
Unique Insiders
11
in the rolling window
Latest filing
Oct 23, 2026
Ceesay Abraham
Rapport Therapeutics, Inc. (RAPP) has 40 SEC Form 4 filings (83 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Oct 23, 2026.
Inside the rolling window, 11 insiders at Rapport Therapeutics, Inc. reported 6 open-market purchases totaling $1.7M and 40 open-market sales totaling $47.2M. The most active filer is Chief Executive Officer Ceesay Abraham with 15 filings. Insiders have net sold $23.6M over the trailing 6 months. The most recent open-market filing is a sale of 2,210 shares by Chief Executive Officer Ceesay Abraham, dated Oct 21, 2026, worth $64K.
- Industry:Biotechnology
- CEO:Abraham N. Ceesay
- Employees:84
- HQ:Boston, MA, US
- IPO:2024-06-07
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 2,210 | $64K | Oct 23 | — | SEC ↗ | |
Sanchez RamiroFirst filing | Director | Purchase | 3,600 | $98K | Oct 23 | — | SEC ↗ |
Silva Paul MFirst filing | Director | Purchase | 3,680 | $100K | Oct 22 | cluster-2.3% | SEC ↗ |
Young Wendy B.First filing | Director | Purchase | 3,789 | $100K | Oct 22 | cluster-2.3% | SEC ↗ |
PAUL STEVEN MFirst filing | Director | Purchase | 35,714 | $974K | Oct 22 | cluster-2.3% | SEC ↗ |
MARAGANORE JOHNFirst filing | Director | Purchase | 9,411 | $249K | Oct 22 | cluster-2.3% | SEC ↗ |
Ignelzi Troy A.First filing | Chief Financial Officer | Purchase | 5,500 | $144K | Oct 21 | cluster+3.5% | SEC ↗ |
| Chief Executive Officer | Sale | 3,375 | $108K | Oct 8 | -13.1% | SEC ↗ | |
| Chief Executive Officer | Sale | 1,147 | $35K | Oct 8 | -13.1% | SEC ↗ | |
Gault CherylFirst in 3 months | Chief Operating Officer | Sale | 10,000 | $332K | Oct 1 | — | SEC ↗ |
| Chief Executive Officer | Sale | 2,210 | $87K | Sep 24 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 8,210 | $374K | Sep 9 | — | SEC ↗ | |
| Chief Development Officer | Sale | 13,160 | $658K | Aug 26 | — | SEC ↗ | |
| Chief Development Officer | Sale | 37,000 | $1.9M | Aug 26 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 18,921 | $938K | Aug 26 | — | SEC ↗ | |
Yeleswaram KrishnaswamyFirst in 4 months | Chief Development Officer | Sale | 404 | $20K | Aug 20 | — | SEC ↗ |
| Chief Executive Officer | Sale | 22,541 | $1.0M | Aug 12 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 28,958 | $1.4M | Aug 12 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 2,210 | $93K | Jul 29 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 8,210 | $328K | Jul 15 | — | SEC ↗ | |
Gault CherylFirst in 3 months | Chief Operating Officer | Sale | 10,000 | $416K | Jul 1 | — | SEC ↗ |
Ceesay AbrahamFirst in 4 months | Chief Executive Officer | Sale | 8,220 | $327K | Jul 1 | — | SEC ↗ |
| 10% Owner | Sale | 18,572 | $744K | May 28 | — | SEC ↗ | |
| 10% Owner | Sale | 133,618 | $5.4M | May 13 | — | SEC ↗ | |
| 10% Owner | Sale | 271,495 | $10.9M | May 11 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does RAPP have?
Rapport Therapeutics, Inc. (RAPP) has 40 SEC Form 4 filings (83 transaction rows) in the rolling 365-day window, disclosed by 11 distinct insiders. Most recent filing: Oct 23, 2026.
When was the most recent SEC Form 4 filing for RAPP?
The most recent Form 4 filing for RAPP on Tracefour is dated Oct 23, 2026.
Who is the most active insider at RAPP?
The most active SEC Form 4 filer at RAPP in the rolling window is Chief Executive Officer Ceesay Abraham, with 15 filings.
What is the net insider flow at RAPP over the last 6 months?
Over the trailing 180 days, insiders at RAPP have net sold $23.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at RAPP in the current window?
Inside the rolling window, insiders at RAPP bought $1.7M and sold $47.2M based on SEC Form 4 filings.
Can I get alerts for RAPP insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Rapport Therapeutics, Inc. (RAPP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Rapport Therapeutics, Inc. is in the Healthcare sector.